DBV Technologies S.A (DBVT) Earnings Date & Reports

DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

DBVT is expected to report earnings to fall 32.14% to -18 cents per share on July 29

DBV Technologies S.A DBVT Stock Earnings Reports

Q2'24

Est.

$-0.19

Q1'24

Missed

by $0.05

Q4'23

Beat

by $0.02

Q3'23

Beat

by $0.07

Q2'23

Missed

by $0.05

The last earnings report on May 07 showed earnings per share of -28 cents, missing the estimate of -23 cents. With 76.73K shares outstanding, the current market capitalization sits at 127.62M.

View a ticker or compare two or three

Compare

DBVT